MedTrace Logo

the Influence of Prophylactic and Empirical Anti-fungal Treatment in Severe Sepsis Patients With Perforations

NCT02941068 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 223

Last updated 2016-10-21

No results posted yet for this study

Summary

This prospective intended to observe the influence of prophylactic and empirical anti-fungal treatment on Severe Sepsis patients with perforations. With the consent of patients' legal guardian for prophylactic use of antifungal agents, patients were divided into two groups: prophylactic group and Empirical group.

Conditions

  • Intra-abdominal Perforation

Interventions

DRUG

fluconazole and caspofungin

Sponsors & Collaborators

  • Nanjing PLA General Hospital

    lead OTHER

Principal Investigators

  • gao tao, ph.d · Nanjing PLA General Hospital

  • cao chun, ph.d · Nanjing PLA General Hospital

  • shi jialiang, ph.d · Nanjing PLA General Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-03-31
Primary Completion
2016-06-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02941068 on ClinicalTrials.gov